Moreover, a small-molecule inhibitor (SMI) of SAMHD1 dNTPase efficiently promoted HIV-1 infection and RT to the same extent as SIVmac239 Vpx treatment, while the Vpx treatment did not further promote HIV replication in the presence of SMI. The gene discussed is SAMHD1; the disease is HIV-1 infection.